Vitatex CAM technology featured in two papers presented at this year's ASCO GI conference in San Francisco.
Manuel Hidalgo, Johns Hopkins University and Centro Integral Oncológico Clara Campal, spoke on use of CTCs isolated by Vitatex CAM platform in a talk entitled “Direct Tumorgraft Mouse Models in Pancreatic Cancer: A Role to Play in Personalized Therapy?" http://gicasym.asco.org/meeting-program
Kenneth H. Yu, MD, Memorial Sloan-Kettering Cancer Center, presented a poster entitled "Use of Pharmacogenomic Modeling in Pancreatic Cancer for Prediction of Chemotherapy Response and Resistance". Vitatex CAM Technology was used to isolate circulating "tumor progrenitor cells" to generate pharmacogenomic profiles predictive of therapy response and resistance in pancreatic cancer. J Clin Oncol 30: 2012 (suppl 34; abstr 142) http://gicasym.asco.org/content/106051-133